Search results

Search results

  1. Rapid Assessment Protocol for Insulin Access: overcoming barriers to care

    Over 80 years after the discovery of insulin, access to it is still problematic for people in many parts of the developing world. In February 2001, at a meeting between the International Diabetes Federation (IDF) and the World Health Organization (WHO), a ...

    admin - 05/20/2008 - 11:24 - - David Beran

  2. Global access to and availability of insulin

    The first practical use of insulin by Banting and Best in 1921 heralded a medical revolution. Overnight, type 1 diabetes went from being a uniformly fatal disease to a manageable disorder. Thousands of people around the world have received awards for survi ...

    admin - 05/20/2008 - 11:25 - - David Beran Ogle Graham Larry Deeb Raab Ron

  3. Diabetes care in Nicaragua: results of the RAPIA study

    Nicaragua, located in Central America, is the second poorest country in the western hemisphere. Around half of its population of 5 million people lives on less than 1 USD per day. Nicaragua is facing a growing burden of non-communicable diseases. In 2000, ...

    admin - 06/25/2008 - 16:20 - - Guadamuz De Castro Adilia Martinez Ana-Julia Tapia Brenda Atlan-Corea Catherine David Beran

  4. Improvements in care for people with diabetes in Mozambique

    An article in this magazine in March 2004 described the Rapid Assessment Protocol for Insulin Access in Mozambique, and some of the results from its implementation. Since it was carried out in 2003, much has changed in Mozambique with regards to access to ...

    admin - 07/08/2008 - 15:33 - - Silva-Matos Carla David Beran

  5. Access to insulin and barriers to care: results of the RAPIA in Vietnam

    people with diabetes face complications and early death. The authors report on an evaluation of the ...

    admin - 12/10/2009 - 09:34 - - David Beran Nguyen Thy Khue Hoang Kim Uoc Le Quang Toan Larry Deeb

  6. Ensuring universal access to insulin – the International Insulin Foundation position statement

  7. Insulin in 2016: challenge and constraints to access